CNTX Stock: The Breast Cancer Clinical Trial Data That Has Context Therapeutics Soaring
Context Therapeutics (NASDAQ:CNTX) stock is rising higher on Friday thanks to results from a Phase 0 ...
Read moreContext Therapeutics (NASDAQ:CNTX) stock is rising higher on Friday thanks to results from a Phase 0 ...
Read moreThe IPC Indice de Precios Y Cotizaciones is down 70.33 points or 0.13% this week to ...
Read moreU.S. stock futures and bond yields crept higher after fresh data on inflation and the labor ...
Read moreIllumina, Inc. (ILMN) is currently at $392.62, up $30.34 or 8.37% -- Would be highest close ...
Read moreOne of the more insidious myths making the rounds this year was that young people didn't ...
Read moreAfter a nearly 29% total return for the S&P 500 this year, history suggests 2022 may ...
Read moreWall Street signBrendan McDermid/Reuters US futures teetered on Friday ahead of monthly employment data, while cases ...
Read moreBy Kosaku Narioka Eisai Co. shares fell as much as 9.2% early Thursday morning after a ...
Read moreAdobe Inc. (ADBE) is currently at $576.60, down $53.74 or 8.52% -- Would be lowest close ...
Read moreText size Investors will be closely watching U.S. inflation numbers for November. The S&P 500 finished ...
Read more© 2022 TheDailyStock.News